(S)-Methyl 2-((S)-2-((2S,3R)-3-Amino-2-hydroxy-5-((2-hydroxyethyl)amino)pentanamido)-4-methylpentanamido)-3-(1H-indol-3-yl)propanoate

ID: ALA5182525

Chembl Id: CHEMBL5182525

PubChem CID: 168282473

Max Phase: Preclinical

Molecular Formula: C25H39N5O6

Molecular Weight: 505.62

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CCNCCO

Standard InChI:  InChI=1S/C25H39N5O6/c1-15(2)12-20(29-24(34)22(32)18(26)8-9-27-10-11-31)23(33)30-21(25(35)36-3)13-16-14-28-19-7-5-4-6-17(16)19/h4-7,14-15,18,20-22,27-28,31-32H,8-13,26H2,1-3H3,(H,29,34)(H,30,33)/t18-,20+,21+,22+/m1/s1

Standard InChI Key:  DJZGVKQMRVQDPK-GBAJDQEWSA-N

Alternative Forms

  1. Parent:

    ALA5182525

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IL1RN Tchem Interleukin-1 receptor antagonist protein (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.62Molecular Weight (Monoisotopic): 505.2900AlogP: -0.44#Rotatable Bonds: 15
Polar Surface Area: 178.80Molecular Species: BASEHBA: 8HBD: 7
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.00CX Basic pKa: 9.04CX LogP: -0.48CX LogD: -2.30
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.13Np Likeness Score: 0.34

References

1. Vourloumis D, Mavridis I, Athanasoulis A, Temponeras I, Koumantou D, Giastas P, Mpakali A, Magrioti V, Leib J, van Endert P, Stratikos E, Papakyriakou A..  (2022)  Discovery of Selective Nanomolar Inhibitors for Insulin-Regulated Aminopeptidase Based on α-Hydroxy-β-amino Acid Derivatives of Bestatin.,  65  (14.0): [PMID:35833347] [10.1021/acs.jmedchem.2c00904]

Source